# A Study of QY101 Ointment in Subjects With Plaque Psoriasis

> **NCT06170840** · PHASE2 · UNKNOWN · sponsor: **E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.** · enrollment: 160 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** QY101Placebo/QY101 ointment

## Key facts

- **NCT ID:** NCT06170840
- **Lead sponsor:** E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-17
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-04-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06170840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06170840, "A Study of QY101 Ointment in Subjects With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06170840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*